Secor Capital Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-20,464
Closed -$793K 536
2018
Q3
$793K Sell
20,464
-7,770
-28% -$280K 0.09% 270
2018
Q2
$945K Buy
28,234
+6,428
+29% +$229K 0.08% 311
2018
Q1
$790K Buy
+21,806
New +$755K 0.07% 316
2017
Q3
Sell
-15,633
Closed -$488K 495
2017
Q2
$488K Sell
15,633
-13,830
-47% -$399K 0.04% 349
2017
Q1
$726K Sell
29,463
-6,926
-19% -$163K 0.08% 293
2016
Q4
$922K Sell
36,389
-8,181
-18% -$182K 0.11% 249
2016
Q3
$884K Buy
+44,570
New +$779K 0.1% 276

Other funds holding LMAT

Secor Capital Advisors's LMAT Position: Q4 2018 in Review

Secor Capital Advisors sold out of LeMaitre Vascular (LMAT) in Q4 2018, closing a stake of 20,464 shares — an estimated $793K sold.

Secor Capital Advisors first reported a position in LMAT in Q3 2016 and held it in 7 quarters. The position peaked at $945K in Q2 2018. 139 funds tracked by Wall St. Rank hold LMAT as of Q4 2018.

  • Secor Capital Advisors reported no remaining LeMaitre Vascular position as of Q4 2018 after selling out during the quarter.
  • Secor Capital Advisors sold 20,464 LeMaitre Vascular shares in Q4 2018, an estimated $793K.
  • Secor Capital Advisors first reported a position in LeMaitre Vascular in Q3 2016 and held it in 7 quarters.
  • Secor Capital Advisors's LeMaitre Vascular position peaked at $945K in Q2 2018.
  • 139 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2018.

Based on Secor Capital Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.